ursodeoxycholic acid has been researched along with Age-Related Osteoporosis in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Combalia, A; Dubreuil, M; Guañabens, N; Jurado, S; Monegal, A; Parés, A; Peris, P; Ruiz-Gaspà, S | 1 |
| Bahar, R; Bowlus, CL; Liu, CH; Wong, KA | 1 |
| Alvarez, L; Combalia, A; Dubreuil, M; Guañabens, N; Monegal, A; Parés, A; Peris, P; Ruiz-Gaspà, S | 1 |
| Parés, A | 1 |
| Kiss, LS; Lakatos, L; Lakatos, PL; Peyrin-Biroulet, L; Schoepfer, A; Vavricka, S | 1 |
| Adler, G; Reinshagen, M | 1 |
| Angulo, P; Dickson, ER; Jorgensen, RA; Keach, JC; Lindor, KD; Smith, C | 1 |
| Heathcote, EJ | 1 |
| Holtmeier, J; Leuschner, U | 1 |
5 review(s) available for ursodeoxycholic acid and Age-Related Osteoporosis
| Article | Year |
|---|---|
Current Treatment Options for Primary Biliary Cholangitis.
Topics: Alkaline Phosphatase; Bezafibrate; Chenodeoxycholic Acid; Cholagogues and Choleretics; Comorbidity; Drug Therapy, Combination; Fenofibrate; Fibroblast Growth Factors; Humans; Hypolipidemic Agents; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Malnutrition; Osteoporosis; Peroxisome Proliferator-Activated Receptors; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2018 |
Old and novel therapies for primary biliary cirrhosis.
Topics: Anti-Inflammatory Agents; Antipruritics; Bile Ducts, Intrahepatic; Bone Density Conservation Agents; Cholagogues and Choleretics; Dietary Supplements; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Liver Cirrhosis, Biliary; Liver Transplantation; Osteoporosis; Pruritus; Treatment Outcome; Ursodeoxycholic Acid | 2014 |
Treatment of extraintestinal manifestations in inflammatory bowel disease.
Topics: Anti-Inflammatory Agents; Anticoagulants; Arthritis; Bone Density Conservation Agents; Cholagogues and Choleretics; Cholangitis, Sclerosing; Eye Diseases; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Osteoporosis; Skin Diseases; Ursodeoxycholic Acid; Venous Thromboembolism | 2012 |
[Extraintestinal manifestations].
Topics: Amyloidosis; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Cholelithiasis; Cohort Studies; Controlled Clinical Trials as Topic; Crohn Disease; Cross-Sectional Studies; Drug Therapy, Combination; Eye Diseases; Humans; Immunosuppressive Agents; Joint Diseases; Kidney Calculi; Kidney Diseases; Liver Diseases; Longitudinal Studies; Lung Diseases; Nervous System Diseases; Osteoporosis; Pancreatitis; Placebos; Prospective Studies; Retrospective Studies; Risk; Risk Factors; Skin Diseases; Thromboembolism; Ursodeoxycholic Acid | 2003 |
Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
Topics: Azathioprine; Celiac Disease; Cholagogues and Choleretics; Cholangitis, Sclerosing; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Liver Cirrhosis, Biliary; Osteoporosis; Prednisolone; Pruritus; Tacrolimus; Ursodeoxycholic Acid | 2001 |
4 other study(ies) available for ursodeoxycholic acid and Age-Related Osteoporosis
| Article | Year |
|---|---|
Bile acids and bilirubin effects on osteoblastic gene profile. Implications in the pathogenesis of osteoporosis in liver diseases.
Topics: Apoptosis; Bile Acids and Salts; Bilirubin; Cell Line, Tumor; Cholestasis; Down-Regulation; Genetic Profile; Humans; Lithocholic Acid; Liver; Liver Diseases; Osteoblasts; Osteoporosis; Osteosarcoma; Up-Regulation; Ursodeoxycholic Acid | 2020 |
Ursodeoxycholic acid increases differentiation and mineralization and neutralizes the damaging effects of bilirubin on osteoblastic cells.
Topics: Bilirubin; Calcification, Physiologic; Cell Differentiation; Cell Line, Tumor; Cell Survival; Cholestasis; Humans; Jaundice; Lithocholic Acid; Osteoblasts; Osteoporosis; Statistics, Nonparametric; Ursodeoxycholic Acid | 2013 |
Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Alkaline Phosphatase; Anti-Inflammatory Agents; Bilirubin; Bone Density; Budesonide; Cholagogues and Choleretics; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Liver Cirrhosis, Biliary; Male; Middle Aged; Osteoporosis; Pilot Projects; Retreatment; Treatment Failure; Ursodeoxycholic Acid | 2000 |
Management of primary biliary cirrhosis. The American Association for the Study of Liver Diseases practice guidelines.
Topics: Autoantibodies; Biopsy; Humans; Hyperbilirubinemia; Hypercholesterolemia; Immunosuppressive Agents; Liver; Liver Cirrhosis, Biliary; Liver Transplantation; Mitochondria; Osteoporosis; Ursodeoxycholic Acid | 2000 |